Pneumonia News

One dose of ceftriaxone lowered the risk for ventilator-associated pneumonia within the first week of mechanical ventilation among patients with acute brain injury, according to results published in The Lancet Respiratory Medicine.

Among older adults who survived a community-acquired pneumonia infection, the risk for cardiovascular mortality 1 year after hospitalization decreased with guideline-concordant antibiotic therapy, according to results published in CHEST.

The FDA in 2023 approved treatments for several hospital-associated infections and fully approved a long-used COVID-19 medication, among other non-vaccine-related regulatory decisions.

Similar to SARS-CoV-2, which can cause long COVID, people hospitalized with influenza are at an increased risk for health issues long after they have cleared the infection, according to a study.

A recombinant influenza vaccine offered additional protection against PCR-confirmed influenza and community-acquired pneumonia hospitalization among adults aged 50 to 64 years compared with a standard-dose vaccine, study results showed.

Fewer critically ill adults who received inhaled amikacin vs. placebo for 3 days developed ventilator-associated pneumonia by day 28, according to results published in The New England Journal of Medicine.

Surgeons used breast implants to hold a man’s heart in place during a double-lung transplant after he was diagnosed with a potentially fatal infection after years of smoking and vaping.

Doxycycline reduced the risk for Clostridioides difficile infection by almost half compared with azithromycin among patients hospitalized with community-acquire pneumonia who had a C. difficile infection in the past year, a study found.

Adults on mechanical ventilation for COVID-19 pneumonia showed improvements in oxygenation with high-dose inhaled nitric oxide, according to results published in American Journal of Respiratory and Critical Care Medicine.

HONOLULU — The risk for all-cause mortality was reduced among patients with community-acquired pneumonia who used hydrocortisone vs. other corticosteroids, according to a poster presented at the CHEST Annual Meeting.